Randomized trials with concurrent economic evaluations reported unrepresentatively large clinical effect sizes

Journal of Clinical Epidemiology

Volumn 60, Issue 8, 2007, Pages 781.e1-781.e10

  Gilbody, Simon ^a   Bower, Peter ^b   Sutton, Alex J ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Depression; Economic evaluation; Meta analysis; Publication bias; Randomized controlled trials; Systematic review

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; ECONOMIC EVALUATION; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

EID: 34250798994     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.10.014     Document Type: Article

References (46)

1. Drummond M.F., O'Brien B., Stoddard G.L., and Torrance G.W. Methods for the economic evaluation of health care programmes (1997), Oxford University Press, Oxford
2. National Institute for Clinical Excellence. A guide to NICE (2005), HMSO, London
3. Drummond M.F., Sculpher M., Stoddard G.L., O'Brien B., and Torrance G.W. Methods for the economic evaluation of health care (2005), Oxford University Press, Oxford
4. Stoykova B., Drummond M., Barbieri M., and Kleijnen J. The lag between effectiveness and cost-effectiveness evidence of new drugs: implications for decision-making in health care. Eur J Health Econ 4 (2003) 313-318
5. Sacristan J., Bolanos E., Hernandez J., Soto J., and Galende I. Publication bias in health economic studies. Pharmacoeconomics 11 (1997) 289-290
6. Bell C., Urbach D.R., Ray J.G., Bayoumi A., Rosen A.B., Greenberg D., et al. Bias in published cost effectiveness studies: systematic review. BMJ 332 (2006) 699-703
7. Sutton A.J., Abrams K.R., Jones D.R., Sheldon T.A., and Song F. Systematic reviews of trials and other studies. Health Technol Assess 2 (1999) 1-276
8. Bower P., Gilbody S.M., Richards D., Fletcher J., and Sutton A. Collaborative care for depression in primary care: making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry 189 (2006) 484-493
9. Gilbody S., Whitty P., Grimshaw J., and Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 289 (2003) 3145-3151
10. Von Korff M. Can care management enhance integration of primary and specialty care?. BMJ 329 (2004) 605
11. Bower P., and Gilbody S. Managing common mental health disorders in primary care: conceptual models and evidence base. BMJ 330 (2005) 839-842
12. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD report 4. 2nd edition (2001), University of York, York
13. Nixon J., Khan K.S., and Kleijnen J. Summarising economic evaluations in systematic reviews: a new approach. BMJ 322 (2001) 1596-1598
14. Higgins J.P.T., and Green S. Cochrane handbook for systematic reviews of interventions 4.2.4. [updated March 2005] (2005), John Wiley & Sons, Ltd, Chichester, UK
15. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
16. Egger M., Davey-Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
17. Von Korff M., Katon W., Bush T., Lin E.H., Simon G.E., Saunders K., et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 60 (1998) 143-149
18. Simon G.E., Von Korff M., Rutter C., and Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 320 (2000) 550-554
19. Schoenbaum M., Unutzer J., Sherbourne C., Duan N., Rubenstein L.V., Miranda J., et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 286 (2001) 1325-1330
20. Simon G.E., Manning W.G., Katzelnick D.J., Pearson S.D., Henk H.J., and Helstad C.S. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 58 (2001) 181-187
21. Simon G.E., Katon W.J., Von Korff M., Unützer J., Lin E.H.B., Walker E.A., et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry 158 (2001) 1638-1644
22. Simon G.E., Von Korff M., Ludman E.J., Katon W.J., Rutter C., Unutzer J., et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Med Care 40 (2002) 941-950
23. Liu C.F., Hedrick S.C., Chaney E.F., Heagerty P., Felker B., Hasenberg N., et al. Cost-effectiveness of collaborative care for depression in a primary care veteran population. Psychiatr Serv 54 (2003) 698-704
24. Pyne J.M., Rost K.M., Zhang M., Williams D.K., Smith J., and Fortney J. Cost-effectiveness of a primary care depression intervention. J Gen Intern Med 18 (2003) 432-441
25. Katon W.J., Schoenbaum M., Fan M.-Y., Callahan C.M., Williams Jr. J., Hunkeler E., et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry 62 (2005) 1313-1320
26. Araya R., Rojas G., Fritsch R., Gaete J., Rojas M., Simon G., et al. Treating depression in primary care in low income women in Santiago, Chile: a randomised controlled trial. Lancet 361 (2003) 995-1000
27. Lave J.R., Frank R.G., Schulberg H.C., and Kamlet M.S. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 55 (1998) 645-651
28. Katon W., Unutzer J., Fan M.-Y., Williams Jr. J.W., Schoenbaum M., Lin E.H., et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29 (2006) 265-270
29. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
30. Higgins J.P.T., and Thompson S.G. Controlling the risk of spurious findings from meta-regression. Stat Med 23 (2004) 1663-1682
31. STATA Corporation. STATA (version 8) (2003), STATA Corporation, College Station, TX
32. Freemantle N., and Mason J. Publication bias in clinical trials and economic analyses. Pharmacoeconomics 12 (1997) 10-16
33. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 263 (1990) 1385-1389
34. Cooper N.J., Coyle D., Abrams K.R., Mugford M., and Sutton A.J. Use of evidence in decision models: an appraisal of health technology assessments in the UK to date. J Health Serv Res Policy 10 (2005) 245-250
35. Sculpher M., Drummond M., and Buxton M.J. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 2 (1997) 26-30
36. Sculpher M., Fenwick E., and Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and examples of application. Pharmacoeconomics 17 (2000) 461-477
37. Coyle D., and Lee K.M. Evidence based economic evaluation: how the use of different data sources can impact results. In: Donaldson C., Mugford M., and Vale L. (Eds). Evidence based health economics: from effectiveness to efficiency in systematic review (2002), BMJ Publishing, London 55-66
38. Jonsson B., and Bebbington P.E. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 164 (1994) 665-673
39. Freemantle N., and Maynard A. Something rotten in the state of clinical and economic evaluations?. Health Econ 3 (1994) 63-67
40. Woods S.W., and Rizzo J.A. Cost-effectiveness of antidepressant treatment reassessed. Br J Psychiatry 170 (1997) 257-263
41. Black W.C. The CE plane: a graphic representation of cost effectiveness. Med Decis Making 10 (1990) 21-24
42. Song F.S., Gilbody S.M., Eastwood A.J., Duley L., and Sutton A.J. Publication and related biases. Health Technol Assess 4 (2000) 1-115
43. Chan A.W., Hrobjartsson A., Haahr M.T., Gotzsche P.C., and Altman D.G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291 (2004) 2457-2465
44. Smith R. New BMJ policy on economic evaluations. BMJ 325 (2002) 1124
45. Krleza-Jeric K., Chan A.-W., Dickersin K., Sim I., Grimshaw J., Gluud C., et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330 (2005) 956-958
46. DeAngelis C.D., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA 292 (2005) 1363-1364